The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Nitinol-based Interventional Device Market Research Report 2025
Synopsis
Nitinol is a special metal that have the ability to restore their original shape after severe deformation. The nitinol medical devices include nitinol stents, nitinol guidewires, nitinol filters etc
The global Nitinol-based Interventional Device market was valued at US$ 21890 million in 2023 and is anticipated to reach US$ 36460 million by 2030, witnessing a CAGR of 7.5% during the forecast period 2024-2030.
The Nitinol-based Interventional Device market is driven by the growing demand for minimally invasive medical procedures and the unique properties of Nitinol alloy in interventional device design. Nitinol, a shape memory alloy, offers remarkable flexibility, shape retention, and biocompatibility, making it an ideal material for various interventional devices like stents, guidewires, and filters. The rise in chronic diseases, such as cardiovascular conditions and peripheral artery diseases, contributes to market growth as healthcare professionals seek advanced devices that ensure precise placement and effective treatment. Moreover, Nitinol's ability to change shape with temperature variations aligns with improved device deployment and reduced patient discomfort. However, the market also faces challenges, including manufacturing complexities due to the unique properties of Nitinol and the need for rigorous testing to ensure device reliability. Additionally, addressing concerns related to long-term device performance and biocompatibility, and managing potential allergic reactions, can pose obstacles for manufacturers. To succeed, companies must focus on material advancements, precise device engineering, and addressing the challenges to provide safe and efficient Nitinol-based interventional devices that enhance patient outcomes and revolutionize minimally invasive medical procedures.
This report aims to provide a comprehensive presentation of the global market for Nitinol-based Interventional Device, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Nitinol-based Interventional Device.
Report Scope
The Nitinol-based Interventional Device market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Nitinol-based Interventional Device market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Nitinol-based Interventional Device manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Abbott
Edwards Lifesciences
Medtronic
Boston Scientific
TERUMO
BD
Stryker
Cook Medical
Cordis
B. Braun
Biotronik
MicroPort
JOTEC
Acandis
ELLA-CS
Segment by Type
Stents
Guidewires
Others
Segment by Application
Hospital
Clinic
Others
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Nitinol-based Interventional Device manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Nitinol-based Interventional Device in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Nitinol is a special metal that have the ability to restore their original shape after severe deformation. The nitinol medical devices include nitinol stents, nitinol guidewires, nitinol filters etc
The global Nitinol-based Interventional Device market was valued at US$ 21890 million in 2023 and is anticipated to reach US$ 36460 million by 2030, witnessing a CAGR of 7.5% during the forecast period 2024-2030.
The Nitinol-based Interventional Device market is driven by the growing demand for minimally invasive medical procedures and the unique properties of Nitinol alloy in interventional device design. Nitinol, a shape memory alloy, offers remarkable flexibility, shape retention, and biocompatibility, making it an ideal material for various interventional devices like stents, guidewires, and filters. The rise in chronic diseases, such as cardiovascular conditions and peripheral artery diseases, contributes to market growth as healthcare professionals seek advanced devices that ensure precise placement and effective treatment. Moreover, Nitinol's ability to change shape with temperature variations aligns with improved device deployment and reduced patient discomfort. However, the market also faces challenges, including manufacturing complexities due to the unique properties of Nitinol and the need for rigorous testing to ensure device reliability. Additionally, addressing concerns related to long-term device performance and biocompatibility, and managing potential allergic reactions, can pose obstacles for manufacturers. To succeed, companies must focus on material advancements, precise device engineering, and addressing the challenges to provide safe and efficient Nitinol-based interventional devices that enhance patient outcomes and revolutionize minimally invasive medical procedures.
This report aims to provide a comprehensive presentation of the global market for Nitinol-based Interventional Device, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Nitinol-based Interventional Device.
Report Scope
The Nitinol-based Interventional Device market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Nitinol-based Interventional Device market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Nitinol-based Interventional Device manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Abbott
Edwards Lifesciences
Medtronic
Boston Scientific
TERUMO
BD
Stryker
Cook Medical
Cordis
B. Braun
Biotronik
MicroPort
JOTEC
Acandis
ELLA-CS
Segment by Type
Stents
Guidewires
Others
Segment by Application
Hospital
Clinic
Others
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Nitinol-based Interventional Device manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Nitinol-based Interventional Device in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index1 Nitinol-based Interventional Device Market Overview
1.1 Product Overview and Scope of Nitinol-based Interventional Device
1.2 Nitinol-based Interventional Device Segment by Type
1.2.1 Global Nitinol-based Interventional Device Market Value Comparison by Type (2024-2030)
1.2.2 Stents
1.2.3 Guidewires
1.2.4 Others
1.3 Nitinol-based Interventional Device Segment by Application
1.3.1 Global Nitinol-based Interventional Device Market Value by Application: (2024-2030)
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Others
1.4 Global Nitinol-based Interventional Device Market Size Estimates and Forecasts
1.4.1 Global Nitinol-based Interventional Device Revenue 2019-2030
1.4.2 Global Nitinol-based Interventional Device Sales 2019-2030
1.4.3 Global Nitinol-based Interventional Device Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Nitinol-based Interventional Device Market Competition by Manufacturers
2.1 Global Nitinol-based Interventional Device Sales Market Share by Manufacturers (2019-2024)
2.2 Global Nitinol-based Interventional Device Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Nitinol-based Interventional Device Average Price by Manufacturers (2019-2024)
2.4 Global Nitinol-based Interventional Device Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Nitinol-based Interventional Device, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Nitinol-based Interventional Device, Product Type & Application
2.7 Nitinol-based Interventional Device Market Competitive Situation and Trends
2.7.1 Nitinol-based Interventional Device Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Nitinol-based Interventional Device Players Market Share by Revenue
2.7.3 Global Nitinol-based Interventional Device Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Nitinol-based Interventional Device Retrospective Market Scenario by Region
3.1 Global Nitinol-based Interventional Device Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Nitinol-based Interventional Device Global Nitinol-based Interventional Device Sales by Region: 2019-2030
3.2.1 Global Nitinol-based Interventional Device Sales by Region: 2019-2024
3.2.2 Global Nitinol-based Interventional Device Sales by Region: 2025-2030
3.3 Global Nitinol-based Interventional Device Global Nitinol-based Interventional Device Revenue by Region: 2019-2030
3.3.1 Global Nitinol-based Interventional Device Revenue by Region: 2019-2024
3.3.2 Global Nitinol-based Interventional Device Revenue by Region: 2025-2030
3.4 North America Nitinol-based Interventional Device Market Facts & Figures by Country
3.4.1 North America Nitinol-based Interventional Device Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Nitinol-based Interventional Device Sales by Country (2019-2030)
3.4.3 North America Nitinol-based Interventional Device Revenue by Country (2019-2030)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Nitinol-based Interventional Device Market Facts & Figures by Country
3.5.1 Europe Nitinol-based Interventional Device Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Nitinol-based Interventional Device Sales by Country (2019-2030)
3.5.3 Europe Nitinol-based Interventional Device Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Nitinol-based Interventional Device Market Facts & Figures by Country
3.6.1 Asia Pacific Nitinol-based Interventional Device Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Nitinol-based Interventional Device Sales by Country (2019-2030)
3.6.3 Asia Pacific Nitinol-based Interventional Device Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Nitinol-based Interventional Device Market Facts & Figures by Country
3.7.1 Latin America Nitinol-based Interventional Device Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Nitinol-based Interventional Device Sales by Country (2019-2030)
3.7.3 Latin America Nitinol-based Interventional Device Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Nitinol-based Interventional Device Market Facts & Figures by Country
3.8.1 Middle East and Africa Nitinol-based Interventional Device Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Nitinol-based Interventional Device Sales by Country (2019-2030)
3.8.3 Middle East and Africa Nitinol-based Interventional Device Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global Nitinol-based Interventional Device Sales by Type (2019-2030)
4.1.1 Global Nitinol-based Interventional Device Sales by Type (2019-2024)
4.1.2 Global Nitinol-based Interventional Device Sales by Type (2025-2030)
4.1.3 Global Nitinol-based Interventional Device Sales Market Share by Type (2019-2030)
4.2 Global Nitinol-based Interventional Device Revenue by Type (2019-2030)
4.2.1 Global Nitinol-based Interventional Device Revenue by Type (2019-2024)
4.2.2 Global Nitinol-based Interventional Device Revenue by Type (2025-2030)
4.2.3 Global Nitinol-based Interventional Device Revenue Market Share by Type (2019-2030)
4.3 Global Nitinol-based Interventional Device Price by Type (2019-2030)
5 Segment by Application
5.1 Global Nitinol-based Interventional Device Sales by Application (2019-2030)
5.1.1 Global Nitinol-based Interventional Device Sales by Application (2019-2024)
5.1.2 Global Nitinol-based Interventional Device Sales by Application (2025-2030)
5.1.3 Global Nitinol-based Interventional Device Sales Market Share by Application (2019-2030)
5.2 Global Nitinol-based Interventional Device Revenue by Application (2019-2030)
5.2.1 Global Nitinol-based Interventional Device Revenue by Application (2019-2024)
5.2.2 Global Nitinol-based Interventional Device Revenue by Application (2025-2030)
5.2.3 Global Nitinol-based Interventional Device Revenue Market Share by Application (2019-2030)
5.3 Global Nitinol-based Interventional Device Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Abbott
6.1.1 Abbott Corporation Information
6.1.2 Abbott Description and Business Overview
6.1.3 Abbott Nitinol-based Interventional Device Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Abbott Nitinol-based Interventional Device Product Portfolio
6.1.5 Abbott Recent Developments/Updates
6.2 Edwards Lifesciences
6.2.1 Edwards Lifesciences Corporation Information
6.2.2 Edwards Lifesciences Description and Business Overview
6.2.3 Edwards Lifesciences Nitinol-based Interventional Device Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Edwards Lifesciences Nitinol-based Interventional Device Product Portfolio
6.2.5 Edwards Lifesciences Recent Developments/Updates
6.3 Medtronic
6.3.1 Medtronic Corporation Information
6.3.2 Medtronic Description and Business Overview
6.3.3 Medtronic Nitinol-based Interventional Device Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Medtronic Nitinol-based Interventional Device Product Portfolio
6.3.5 Medtronic Recent Developments/Updates
6.4 Boston Scientific
6.4.1 Boston Scientific Corporation Information
6.4.2 Boston Scientific Description and Business Overview
6.4.3 Boston Scientific Nitinol-based Interventional Device Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Boston Scientific Nitinol-based Interventional Device Product Portfolio
6.4.5 Boston Scientific Recent Developments/Updates
6.5 TERUMO
6.5.1 TERUMO Corporation Information
6.5.2 TERUMO Description and Business Overview
6.5.3 TERUMO Nitinol-based Interventional Device Sales, Revenue and Gross Margin (2019-2024)
6.5.4 TERUMO Nitinol-based Interventional Device Product Portfolio
6.5.5 TERUMO Recent Developments/Updates
6.6 BD
6.6.1 BD Corporation Information
6.6.2 BD Description and Business Overview
6.6.3 BD Nitinol-based Interventional Device Sales, Revenue and Gross Margin (2019-2024)
6.6.4 BD Nitinol-based Interventional Device Product Portfolio
6.6.5 BD Recent Developments/Updates
6.7 Stryker
6.6.1 Stryker Corporation Information
6.6.2 Stryker Description and Business Overview
6.6.3 Stryker Nitinol-based Interventional Device Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Stryker Nitinol-based Interventional Device Product Portfolio
6.7.5 Stryker Recent Developments/Updates
6.8 Cook Medical
6.8.1 Cook Medical Corporation Information
6.8.2 Cook Medical Description and Business Overview
6.8.3 Cook Medical Nitinol-based Interventional Device Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Cook Medical Nitinol-based Interventional Device Product Portfolio
6.8.5 Cook Medical Recent Developments/Updates
6.9 Cordis
6.9.1 Cordis Corporation Information
6.9.2 Cordis Description and Business Overview
6.9.3 Cordis Nitinol-based Interventional Device Sales, Revenue and Gross Margin (2019-2024)
6.9.4 Cordis Nitinol-based Interventional Device Product Portfolio
6.9.5 Cordis Recent Developments/Updates
6.10 B. Braun
6.10.1 B. Braun Corporation Information
6.10.2 B. Braun Description and Business Overview
6.10.3 B. Braun Nitinol-based Interventional Device Sales, Revenue and Gross Margin (2019-2024)
6.10.4 B. Braun Nitinol-based Interventional Device Product Portfolio
6.10.5 B. Braun Recent Developments/Updates
6.11 Biotronik
6.11.1 Biotronik Corporation Information
6.11.2 Biotronik Nitinol-based Interventional Device Description and Business Overview
6.11.3 Biotronik Nitinol-based Interventional Device Sales, Revenue and Gross Margin (2019-2024)
6.11.4 Biotronik Nitinol-based Interventional Device Product Portfolio
6.11.5 Biotronik Recent Developments/Updates
6.12 MicroPort
6.12.1 MicroPort Corporation Information
6.12.2 MicroPort Nitinol-based Interventional Device Description and Business Overview
6.12.3 MicroPort Nitinol-based Interventional Device Sales, Revenue and Gross Margin (2019-2024)
6.12.4 MicroPort Nitinol-based Interventional Device Product Portfolio
6.12.5 MicroPort Recent Developments/Updates
6.13 JOTEC
6.13.1 JOTEC Corporation Information
6.13.2 JOTEC Nitinol-based Interventional Device Description and Business Overview
6.13.3 JOTEC Nitinol-based Interventional Device Sales, Revenue and Gross Margin (2019-2024)
6.13.4 JOTEC Nitinol-based Interventional Device Product Portfolio
6.13.5 JOTEC Recent Developments/Updates
6.14 Acandis
6.14.1 Acandis Corporation Information
6.14.2 Acandis Nitinol-based Interventional Device Description and Business Overview
6.14.3 Acandis Nitinol-based Interventional Device Sales, Revenue and Gross Margin (2019-2024)
6.14.4 Acandis Nitinol-based Interventional Device Product Portfolio
6.14.5 Acandis Recent Developments/Updates
6.15 ELLA-CS
6.15.1 ELLA-CS Corporation Information
6.15.2 ELLA-CS Nitinol-based Interventional Device Description and Business Overview
6.15.3 ELLA-CS Nitinol-based Interventional Device Sales, Revenue and Gross Margin (2019-2024)
6.15.4 ELLA-CS Nitinol-based Interventional Device Product Portfolio
6.15.5 ELLA-CS Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Nitinol-based Interventional Device Industry Chain Analysis
7.2 Nitinol-based Interventional Device Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Nitinol-based Interventional Device Production Mode & Process
7.4 Nitinol-based Interventional Device Sales and Marketing
7.4.1 Nitinol-based Interventional Device Sales Channels
7.4.2 Nitinol-based Interventional Device Distributors
7.5 Nitinol-based Interventional Device Customers
8 Nitinol-based Interventional Device Market Dynamics
8.1 Nitinol-based Interventional Device Industry Trends
8.2 Nitinol-based Interventional Device Market Drivers
8.3 Nitinol-based Interventional Device Market Challenges
8.4 Nitinol-based Interventional Device Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of TablesList of Tables
Table 1. Global Nitinol-based Interventional Device Market Value Comparison by Type (2024-2030) & (US$ Million)
Table 2. Global Nitinol-based Interventional Device Market Value Comparison by Application (2024-2030) & (US$ Million)
Table 3. Global Nitinol-based Interventional Device Market Competitive Situation by Manufacturers in 2023
Table 4. Global Nitinol-based Interventional Device Sales (K Units) of Key Manufacturers (2019-2024)
Table 5. Global Nitinol-based Interventional Device Sales Market Share by Manufacturers (2019-2024)
Table 6. Global Nitinol-based Interventional Device Revenue (US$ Million) by Manufacturers (2019-2024)
Table 7. Global Nitinol-based Interventional Device Revenue Share by Manufacturers (2019-2024)
Table 8. Global Market Nitinol-based Interventional Device Average Price (US$/Unit) of Key Manufacturers (2019-2024)
Table 9. Global Key Players of Nitinol-based Interventional Device, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Nitinol-based Interventional Device, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Nitinol-based Interventional Device, Product Type & Application
Table 12. Global Key Manufacturers of Nitinol-based Interventional Device, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Nitinol-based Interventional Device by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Nitinol-based Interventional Device as of 2023)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Nitinol-based Interventional Device Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 17. Global Nitinol-based Interventional Device Sales by Region (2019-2024) & (K Units)
Table 18. Global Nitinol-based Interventional Device Sales Market Share by Region (2019-2024)
Table 19. Global Nitinol-based Interventional Device Sales by Region (2025-2030) & (K Units)
Table 20. Global Nitinol-based Interventional Device Sales Market Share by Region (2025-2030)
Table 21. Global Nitinol-based Interventional Device Revenue by Region (2019-2024) & (US$ Million)
Table 22. Global Nitinol-based Interventional Device Revenue Market Share by Region (2019-2024)
Table 23. Global Nitinol-based Interventional Device Revenue by Region (2025-2030) & (US$ Million)
Table 24. Global Nitinol-based Interventional Device Revenue Market Share by Region (2025-2030)
Table 25. North America Nitinol-based Interventional Device Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 26. North America Nitinol-based Interventional Device Sales by Country (2019-2024) & (K Units)
Table 27. North America Nitinol-based Interventional Device Sales by Country (2025-2030) & (K Units)
Table 28. North America Nitinol-based Interventional Device Revenue by Country (2019-2024) & (US$ Million)
Table 29. North America Nitinol-based Interventional Device Revenue by Country (2025-2030) & (US$ Million)
Table 30. Europe Nitinol-based Interventional Device Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 31. Europe Nitinol-based Interventional Device Sales by Country (2019-2024) & (K Units)
Table 32. Europe Nitinol-based Interventional Device Sales by Country (2025-2030) & (K Units)
Table 33. Europe Nitinol-based Interventional Device Revenue by Country (2019-2024) & (US$ Million)
Table 34. Europe Nitinol-based Interventional Device Revenue by Country (2025-2030) & (US$ Million)
Table 35. Asia Pacific Nitinol-based Interventional Device Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 36. Asia Pacific Nitinol-based Interventional Device Sales by Region (2019-2024) & (K Units)
Table 37. Asia Pacific Nitinol-based Interventional Device Sales by Region (2025-2030) & (K Units)
Table 38. Asia Pacific Nitinol-based Interventional Device Revenue by Region (2019-2024) & (US$ Million)
Table 39. Asia Pacific Nitinol-based Interventional Device Revenue by Region (2025-2030) & (US$ Million)
Table 40. Latin America Nitinol-based Interventional Device Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 41. Latin America Nitinol-based Interventional Device Sales by Country (2019-2024) & (K Units)
Table 42. Latin America Nitinol-based Interventional Device Sales by Country (2025-2030) & (K Units)
Table 43. Latin America Nitinol-based Interventional Device Revenue by Country (2019-2024) & (US$ Million)
Table 44. Latin America Nitinol-based Interventional Device Revenue by Country (2025-2030) & (US$ Million)
Table 45. Middle East & Africa Nitinol-based Interventional Device Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 46. Middle East & Africa Nitinol-based Interventional Device Sales by Country (2019-2024) & (K Units)
Table 47. Middle East & Africa Nitinol-based Interventional Device Sales by Country (2025-2030) & (K Units)
Table 48. Middle East & Africa Nitinol-based Interventional Device Revenue by Country (2019-2024) & (US$ Million)
Table 49. Middle East & Africa Nitinol-based Interventional Device Revenue by Country (2025-2030) & (US$ Million)
Table 50. Global Nitinol-based Interventional Device Sales (K Units) by Type (2019-2024)
Table 51. Global Nitinol-based Interventional Device Sales (K Units) by Type (2025-2030)
Table 52. Global Nitinol-based Interventional Device Sales Market Share by Type (2019-2024)
Table 53. Global Nitinol-based Interventional Device Sales Market Share by Type (2025-2030)
Table 54. Global Nitinol-based Interventional Device Revenue (US$ Million) by Type (2019-2024)
Table 55. Global Nitinol-based Interventional Device Revenue (US$ Million) by Type (2025-2030)
Table 56. Global Nitinol-based Interventional Device Revenue Market Share by Type (2019-2024)
Table 57. Global Nitinol-based Interventional Device Revenue Market Share by Type (2025-2030)
Table 58. Global Nitinol-based Interventional Device Price (US$/Unit) by Type (2019-2024)
Table 59. Global Nitinol-based Interventional Device Price (US$/Unit) by Type (2025-2030)
Table 60. Global Nitinol-based Interventional Device Sales (K Units) by Application (2019-2024)
Table 61. Global Nitinol-based Interventional Device Sales (K Units) by Application (2025-2030)
Table 62. Global Nitinol-based Interventional Device Sales Market Share by Application (2019-2024)
Table 63. Global Nitinol-based Interventional Device Sales Market Share by Application (2025-2030)
Table 64. Global Nitinol-based Interventional Device Revenue (US$ Million) by Application (2019-2024)
Table 65. Global Nitinol-based Interventional Device Revenue (US$ Million) by Application (2025-2030)
Table 66. Global Nitinol-based Interventional Device Revenue Market Share by Application (2019-2024)
Table 67. Global Nitinol-based Interventional Device Revenue Market Share by Application (2025-2030)
Table 68. Global Nitinol-based Interventional Device Price (US$/Unit) by Application (2019-2024)
Table 69. Global Nitinol-based Interventional Device Price (US$/Unit) by Application (2025-2030)
Table 70. Abbott Corporation Information
Table 71. Abbott Description and Business Overview
Table 72. Abbott Nitinol-based Interventional Device Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 73. Abbott Nitinol-based Interventional Device Product
Table 74. Abbott Recent Developments/Updates
Table 75. Edwards Lifesciences Corporation Information
Table 76. Edwards Lifesciences Description and Business Overview
Table 77. Edwards Lifesciences Nitinol-based Interventional Device Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 78. Edwards Lifesciences Nitinol-based Interventional Device Product
Table 79. Edwards Lifesciences Recent Developments/Updates
Table 80. Medtronic Corporation Information
Table 81. Medtronic Description and Business Overview
Table 82. Medtronic Nitinol-based Interventional Device Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 83. Medtronic Nitinol-based Interventional Device Product
Table 84. Medtronic Recent Developments/Updates
Table 85. Boston Scientific Corporation Information
Table 86. Boston Scientific Description and Business Overview
Table 87. Boston Scientific Nitinol-based Interventional Device Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 88. Boston Scientific Nitinol-based Interventional Device Product
Table 89. Boston Scientific Recent Developments/Updates
Table 90. TERUMO Corporation Information
Table 91. TERUMO Description and Business Overview
Table 92. TERUMO Nitinol-based Interventional Device Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 93. TERUMO Nitinol-based Interventional Device Product
Table 94. TERUMO Recent Developments/Updates
Table 95. BD Corporation Information
Table 96. BD Description and Business Overview
Table 97. BD Nitinol-based Interventional Device Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 98. BD Nitinol-based Interventional Device Product
Table 99. BD Recent Developments/Updates
Table 100. Stryker Corporation Information
Table 101. Stryker Description and Business Overview
Table 102. Stryker Nitinol-based Interventional Device Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 103. Stryker Nitinol-based Interventional Device Product
Table 104. Stryker Recent Developments/Updates
Table 105. Cook Medical Corporation Information
Table 106. Cook Medical Description and Business Overview
Table 107. Cook Medical Nitinol-based Interventional Device Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 108. Cook Medical Nitinol-based Interventional Device Product
Table 109. Cook Medical Recent Developments/Updates
Table 110. Cordis Corporation Information
Table 111. Cordis Description and Business Overview
Table 112. Cordis Nitinol-based Interventional Device Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 113. Cordis Nitinol-based Interventional Device Product
Table 114. Cordis Recent Developments/Updates
Table 115. B. Braun Corporation Information
Table 116. B. Braun Description and Business Overview
Table 117. B. Braun Nitinol-based Interventional Device Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 118. B. Braun Nitinol-based Interventional Device Product
Table 119. B. Braun Recent Developments/Updates
Table 120. Biotronik Corporation Information
Table 121. Biotronik Description and Business Overview
Table 122. Biotronik Nitinol-based Interventional Device Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 123. Biotronik Nitinol-based Interventional Device Product
Table 124. Biotronik Recent Developments/Updates
Table 125. MicroPort Corporation Information
Table 126. MicroPort Description and Business Overview
Table 127. MicroPort Nitinol-based Interventional Device Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 128. MicroPort Nitinol-based Interventional Device Product
Table 129. MicroPort Recent Developments/Updates
Table 130. JOTEC Corporation Information
Table 131. JOTEC Description and Business Overview
Table 132. JOTEC Nitinol-based Interventional Device Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 133. JOTEC Nitinol-based Interventional Device Product
Table 134. JOTEC Recent Developments/Updates
Table 135. Acandis Corporation Information
Table 136. Acandis Description and Business Overview
Table 137. Acandis Nitinol-based Interventional Device Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 138. Acandis Nitinol-based Interventional Device Product
Table 139. Acandis Recent Developments/Updates
Table 140. ELLA-CS Corporation Information
Table 141. ELLA-CS Description and Business Overview
Table 142. ELLA-CS Nitinol-based Interventional Device Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 143. ELLA-CS Nitinol-based Interventional Device Product
Table 144. ELLA-CS Recent Developments/Updates
Table 145. Key Raw Materials Lists
Table 146. Raw Materials Key Suppliers Lists
Table 147. Nitinol-based Interventional Device Distributors List
Table 148. Nitinol-based Interventional Device Customers List
Table 149. Nitinol-based Interventional Device Market Trends
Table 150. Nitinol-based Interventional Device Market Drivers
Table 151. Nitinol-based Interventional Device Market Challenges
Table 152. Nitinol-based Interventional Device Market Restraints
Table 153. Research Programs/Design for This Report
Table 154. Key Data Information from Secondary Sources
Table 155. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Nitinol-based Interventional Device
Figure 2. Global Nitinol-based Interventional Device Market Value Comparison by Type (2024-2030) & (US$ Million)
Figure 3. Global Nitinol-based Interventional Device Market Share by Type in 2023 & 2030
Figure 4. Stents Product Picture
Figure 5. Guidewires Product Picture
Figure 6. Others Product Picture
Figure 7. Global Nitinol-based Interventional Device Market Value Comparison by Application (2024-2030) & (US$ Million)
Figure 8. Global Nitinol-based Interventional Device Market Share by Application in 2023 & 2030
Figure 9. Hospital
Figure 10. Clinic
Figure 11. Others
Figure 12. Global Nitinol-based Interventional Device Revenue, (US$ Million), 2019 VS 2023 VS 2030
Figure 13. Global Nitinol-based Interventional Device Market Size (2019-2030) & (US$ Million)
Figure 14. Global Nitinol-based Interventional Device Sales (2019-2030) & (K Units)
Figure 15. Global Nitinol-based Interventional Device Average Price (US$/Unit) & (2019-2030)
Figure 16. Nitinol-based Interventional Device Report Years Considered
Figure 17. Nitinol-based Interventional Device Sales Share by Manufacturers in 2023
Figure 18. Global Nitinol-based Interventional Device Revenue Share by Manufacturers in 2023
Figure 19. The Global 5 and 10 Largest Nitinol-based Interventional Device Players: Market Share by Revenue in 2023
Figure 20. Nitinol-based Interventional Device Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2019 VS 2023
Figure 21. Global Nitinol-based Interventional Device Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Figure 22. North America Nitinol-based Interventional Device Sales Market Share by Country (2019-2030)
Figure 23. North America Nitinol-based Interventional Device Revenue Market Share by Country (2019-2030)
Figure 24. U.S. Nitinol-based Interventional Device Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 25. Canada Nitinol-based Interventional Device Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 26. Europe Nitinol-based Interventional Device Sales Market Share by Country (2019-2030)
Figure 27. Europe Nitinol-based Interventional Device Revenue Market Share by Country (2019-2030)
Figure 28. Germany Nitinol-based Interventional Device Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 29. France Nitinol-based Interventional Device Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 30. U.K. Nitinol-based Interventional Device Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 31. Italy Nitinol-based Interventional Device Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 32. Russia Nitinol-based Interventional Device Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 33. Asia Pacific Nitinol-based Interventional Device Sales Market Share by Region (2019-2030)
Figure 34. Asia Pacific Nitinol-based Interventional Device Revenue Market Share by Region (2019-2030)
Figure 35. China Nitinol-based Interventional Device Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 36. Japan Nitinol-based Interventional Device Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 37. South Korea Nitinol-based Interventional Device Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 38. India Nitinol-based Interventional Device Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 39. Australia Nitinol-based Interventional Device Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 40. Taiwan Nitinol-based Interventional Device Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 41. Indonesia Nitinol-based Interventional Device Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 42. Thailand Nitinol-based Interventional Device Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 43. Malaysia Nitinol-based Interventional Device Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 44. Philippines Nitinol-based Interventional Device Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 45. Latin America Nitinol-based Interventional Device Sales Market Share by Country (2019-2030)
Figure 46. Latin America Nitinol-based Interventional Device Revenue Market Share by Country (2019-2030)
Figure 47. Mexico Nitinol-based Interventional Device Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 48. Brazil Nitinol-based Interventional Device Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 49. Argentina Nitinol-based Interventional Device Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 50. Middle East & Africa Nitinol-based Interventional Device Sales Market Share by Country (2019-2030)
Figure 51. Middle East & Africa Nitinol-based Interventional Device Revenue Market Share by Country (2019-2030)
Figure 52. Turkey Nitinol-based Interventional Device Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 53. Saudi Arabia Nitinol-based Interventional Device Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 54. U.A.E Nitinol-based Interventional Device Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 55. Global Sales Market Share of Nitinol-based Interventional Device by Type (2019-2030)
Figure 56. Global Revenue Market Share of Nitinol-based Interventional Device by Type (2019-2030)
Figure 57. Global Nitinol-based Interventional Device Price (US$/Unit) by Type (2019-2030)
Figure 58. Global Sales Market Share of Nitinol-based Interventional Device by Application (2019-2030)
Figure 59. Global Revenue Market Share of Nitinol-based Interventional Device by Application (2019-2030)
Figure 60. Global Nitinol-based Interventional Device Price (US$/Unit) by Application (2019-2030)
Figure 61. Nitinol-based Interventional Device Value Chain
Figure 62. Nitinol-based Interventional Device Production Process
Figure 63. Channels of Distribution (Direct Vs Distribution)
Figure 64. Distributors Profiles
Figure 65. Bottom-up and Top-down Approaches for This Report
Figure 66. Data Triangulation
Figure 67. Key Executives Interviewed
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
